Imax price target raised to $36 from $32 at Roth Capital

Roth Capital analyst Eric Handler raised the firm’s price target on Imax (IMAX) to $36 from $32 and keeps a Buy rating on the shares after hosting talks with its senior management. IMAX’s global box office is seeing a sizable resurgence and is on track to meet or beat 2025 guidance of $1.2B, while the company’s market share is rising with improved utilization, the analyst tells investors in a research note. Theatre operator demand for new systems also remains robust, particularly in markets with above average revenue per screen, Roth added.